首页/数据集/Complete success and qualified success comparing antimetabolites with anti-VEGF agents.

Complete success and qualified success comparing antimetabolites with anti-VEGF agents.

Figshare2015-12-02 更新2026-04-29 收录

数据链接：

https://figshare.com/articles/dataset/_Complete_success_and_qualified_success_comparing_antimetabolites_with_anti_VEGF_agents_/929793 数据链接链接失效反馈

官方服务：

资源简介：

RCT = prospective randomized controlled trial; Pro = prospective non-randomized.

应用场景：

创建时间：

2015-12-02

癌症靶向治疗

药物疗效比较

Purpose A variety of targeted drug were developed and proved effective and safe in clinical trials. Our study aims to compare the efficacies and safety of different targeted drugs in advanced hepatoce

NIAID Data Ecosystem50

Supplementary Material for: Ticagrelor versus Prasugrel in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention - analysis from the Acute Coronary Syndrome Israeli Survey (ACSIS)

药物疗效比较

急性冠状动脉综合征

Introduction: We aimed to compare the outcomes of ACS (acute coronary syndrome) patients undergoing in-hospital PCI (percutaneous coronary intervention) treated with prasugrel versus ticagrelor. Metho

Figshare2021-11-22 更新20

Supplementary Material for "Comparative efficacy of biologics and oral agents in palmoplantar psoriasis and palmoplantar pustulosis: A systematic review and network meta-analysis of randomized clinical trials"

皮肤病治疗

药物疗效比较

Supplementary tables and figures for the paper titled "Comparative efficacy of biologics and oral agents in palmoplantar psoriasis and palmoplantar pustulosis: A systematic review and network meta-ana

Mendeley Data10

Table S1 - Persistence on Therapy and Propensity Matched Outcome Comparison of Two Subcutaneous Interferon Beta 1a Dosages for Multiple Sclerosis

多发性硬化症治疗

药物疗效比较

Assignation to treatment dosage by treating centres. The table shows number of patients assigned to either Rebif dosage at each of the participating centres. Odds relative to the reference centre (IT-

Figshare2015-12-02 更新30

Clinical data of baseline and 12-month follow-up in RTX and CTX groups.

药物疗效比较

纵向研究

Clinical data of baseline and 12-month follow-up in RTX and CTX groups.

NIAID Data Ecosystem20